We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of PRVB yet.

PRVB Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q3 2023, worth a combined $0 — down 100% from $2.8M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PRVB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS AM, exiting entirely with an estimated $2.8M sold.

  • 0 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q3 2023, down from 1 in Q2 2023.
  • Funds reported $0 of Provention Bio, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Provention Bio, Inc. Common Stock positions in Q3 2023 and 1 closed out, a net change of -1 holder.
  • The largest Provention Bio, Inc. Common Stock seller in Q3 2023 was UBS AM, an estimated $2.8M sold.

Based on aggregated 13F filings for Q3 2023.